Literature DB >> 16005856

Functional expression of P2X7 receptors in non-neuronal cells of rat dorsal root ganglia.

Xu-Feng Zhang1, Ping Han, Connie R Faltynek, Michael F Jarvis, Char-Chang Shieh.   

Abstract

The P2X7 receptor is an ATP-sensitive ligand-gated cation channel, expressed predominantly in cells with immune origin. Recent studies have demonstrated that P2X7 may play an important role in pain signaling. In the present study, the expression of P2X7 receptors in non-neuronal cells and neurons isolated from dorsal root ganglia was characterized using patch clamp, pharmacological and confocal microscopy approaches. In small diameter DRG neurons, 100 microM 2', 3'-O-(4-benzoylbenzoyl)-ATP (BzATP) evoked an inward current, which was inhibited completely by 1 microM A-317491, a potent and selective P2X3 receptor antagonist. In contrast, BzATP evoked concentration-dependent increases in inward currents in non-neuronal DRG cells with an EC50 value of 26 +/- 0.14 microM, which were resistant to the blockade by A-317491. The activity to evoke cationic currents by P2X receptor agonists in non-neuronal cells showed a rank order of BzATP > ATP > alpha,beta-meATP. Pyridoxal-phosphate-6-azophenyl-,2',4'-disulphonic acid (PPADS) and Mg2+ produced concentration-dependent inhibition of BzATP-evoked currents in non-neuronal cells. Confocal microscopy revealed positive immunoreactivity of anti-P2X7 receptor antibodies on non-neuronal cells. No anti-P2X7 immunoreactivity was observed on DRG neurons. Further electrophysiological studies showed that prolonged agonist activation of P2X7 receptors in non-neuronal cells did not lead to cytolytic pore formation. Taken together, the present study demonstrated functional expression of P2X7 receptors in non-neuronal but not in small diameter neurons from rat DRG. Modulation of P2X7 receptors in non-neuronal cells might have impact on peripheral sensory transduction under normal and pathological states.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005856     DOI: 10.1016/j.brainres.2005.06.022

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  35 in total

1.  C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation.

Authors:  Sébastien Roger; Ludovic Gillet; Alberto Baroja-Mazo; Annmarie Surprenant; Pablo Pelegrin
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

2.  P2X7R large pore is partially blocked by pore forming proteins antagonists in astrocytes.

Authors:  Robson X Faria; Ricardo A M Reis; Leonardo G B Ferreira; Paula F T Cezar-de-Mello; Milton O Moraes
Journal:  J Bioenerg Biomembr       Date:  2016-01-30       Impact factor: 2.945

Review 3.  P2X3 receptor involvement in pain states.

Authors:  Kerstin Wirkner; Beata Sperlagh; Peter Illes
Journal:  Mol Neurobiol       Date:  2007-07-17       Impact factor: 5.590

Review 4.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

5.  Activation of P2X7 receptors in glial satellite cells reduces pain through downregulation of P2X3 receptors in nociceptive neurons.

Authors:  Yong Chen; Xiaofei Zhang; Congying Wang; Guangwen Li; Yanping Gu; Li-Yen Mae Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

6.  Purinergic receptor immunoreactivity in the rostral ventromedial medulla.

Authors:  L N Close; J S Cetas; M M Heinricher; N R Selden
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

7.  Distribution of purinergic P2X receptors in the equine digit, cervical spinal cord and dorsal root ganglia.

Authors:  D E Zamboulis; J M Senior; P D Clegg; J A Gallagher; S D Carter; P I Milner
Journal:  Purinergic Signal       Date:  2013-02-06       Impact factor: 3.765

8.  Novel P2X7 receptor antagonists ease the pain.

Authors:  B F King
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

Review 9.  Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.

Authors:  D L Donnelly-Roberts; M F Jarvis
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

10.  Identification and characterization of a novel variant of the human P2X(7) receptor resulting in gain of function.

Authors:  Chengqun Sun; Jessica Chu; Sarita Singh; Russell D Salter
Journal:  Purinergic Signal       Date:  2009-10-17       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.